1. Home
  2. WST vs HOLX Comparison

WST vs HOLX Comparison

Compare WST & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$250.97

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$75.47

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
HOLX
Founded
1923
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6B
16.6B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
WST
HOLX
Price
$250.97
$75.47
Analyst Decision
Buy
Hold
Analyst Count
7
13
Target Price
$319.43
$77.89
AVG Volume (30 Days)
949.4K
2.2M
Earning Date
05-15-2026
04-27-2026
Dividend Yield
0.35%
N/A
EPS Growth
1.49
N/A
EPS
6.79
0.79
Revenue
$2,886,900,000.00
$4,100,500,000.00
Revenue This Year
$6.83
$4.74
Revenue Next Year
$6.18
$5.03
P/E Ratio
$37.00
$95.50
Revenue Growth
1.95
1.74
52 Week Low
$187.43
$51.90
52 Week High
$322.34
$75.49

Technical Indicators

Market Signals
Indicator
WST
HOLX
Relative Strength Index (RSI) 52.31 62.81
Support Level $244.30 $74.53
Resistance Level $261.98 N/A
Average True Range (ATR) 8.31 0.21
MACD 1.82 0.02
Stochastic Oscillator 72.45 95.87

Price Performance

Historical Comparison
WST
HOLX

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: